Literature DB >> 21589435

3,6,8-Tribromo-quinoline.

Ismail Celik, Mehmet Akkurt, Salih Okten, Osman Cakmak, Santiago García-Granda.   

Abstract

The title mol-ecule, C(9)H(4)Br(3)N, is almost planar, the maximum deviation being 0.110 (1) Å. The crystal structure is stabilized by weak aromatic π-π inter-actions [centroid-centroid distance = 3.802 (4) Å] between the pyridine and benzene rings of the quinoline ring systems of adjacent mol-ecules.

Entities:  

Year:  2010        PMID: 21589435      PMCID: PMC3011610          DOI: 10.1107/S1600536810045484

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For background to the synthesis of natural biologically active quinoline derivatives and for the synthesis of the title compound, see: Şahin et al. (2008 ▶). For the structure of 6,8-dibromo­quinoline, see: Çelik et al. (2010 ▶).

Experimental

Crystal data

C9H4Br3N M = 365.83 Monoclinic, a = 3.9810 (2) Å b = 12.4176 (4) Å c = 19.7419 (6) Å β = 92.827 (3)° V = 974.74 (7) Å3 Z = 4 Cu Kα radiation μ = 14.93 mm−1 T = 296 K 0.51 × 0.06 × 0.03 mm

Data collection

Oxford Diffraction Xcalibur diffractometer with a Ruby Gemini CCD detector Absorption correction: multi-scan (CrysAlis PRO; Oxford Diffraction, 2010 ▶) T min = 0.049, T max = 0.663 3688 measured reflections 1816 independent reflections 1484 reflections with I > 2σ(I) R int = 0.060

Refinement

R[F 2 > 2σ(F 2)] = 0.054 wR(F 2) = 0.150 S = 1.05 1816 reflections 118 parameters H-atom parameters constrained Δρmax = 1.45 e Å−3 Δρmin = −0.80 e Å−3 Data collection: CrysAlis PRO (Oxford Diffraction, 2010 ▶); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SIR97 (Altomare et al., 1999 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1999 ▶); software used to prepare material for publication: WinGX (Farrugia, 1997 ▶) and PLATON (Spek, 2009 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536810045484/pv2350sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810045484/pv2350Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C9H4Br3NF(000) = 680
Mr = 365.83Dx = 2.493 Mg m3
Monoclinic, P21/nCu Kα radiation, λ = 1.5418 Å
Hall symbol: -P 2ynCell parameters from 2025 reflections
a = 3.9810 (2) Åθ = 3.6–70.4°
b = 12.4176 (4) ŵ = 14.93 mm1
c = 19.7419 (6) ÅT = 296 K
β = 92.827 (3)°Needle, colourless
V = 974.74 (7) Å30.51 × 0.06 × 0.03 mm
Z = 4
Oxford Diffraction Xcalibur diffractometer with a Ruby Gemini CCD detector1816 independent reflections
Radiation source: Enhance (Cu) X-ray Source1484 reflections with I > 2σ(I)
graphiteRint = 0.060
Detector resolution: 10.2673 pixels mm-1θmax = 70.6°, θmin = 5.7°
ω scansh = −4→4
Absorption correction: multi-scan (CrysAlis PRO; Oxford Diffraction, 2010)k = −9→15
Tmin = 0.049, Tmax = 0.663l = −22→24
3688 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.054Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.150H-atom parameters constrained
S = 1.05w = 1/[σ2(Fo2) + (0.1066P)2] where P = (Fo2 + 2Fc2)/3
1816 reflections(Δ/σ)max = 0.001
118 parametersΔρmax = 1.45 e Å3
0 restraintsΔρmin = −0.79 e Å3
Geometry. Bond distances, angles etc. have been calculated using the rounded fractional coordinates. All su's are estimated from the variances of the (full) variance-covariance matrix. The cell e.s.d.'s are taken into account in the estimation of distances, angles and torsion angles
Refinement. Refinement on F2 for ALL reflections except those flagged by the user for potential systematic errors. Weighted R-factors wR and all goodnesses of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The observed criterion of F2 > σ(F2) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
xyzUiso*/Ueq
Br10.6380 (2)0.29099 (6)0.90189 (4)0.0568 (3)
Br20.11453 (19)−0.12590 (6)0.92944 (4)0.0525 (3)
Br30.7497 (2)0.08258 (7)0.56672 (4)0.0608 (3)
N10.7203 (14)0.2168 (5)0.7553 (3)0.0440 (17)
C10.5666 (16)0.1396 (5)0.7921 (3)0.0396 (17)
C20.5134 (15)0.1576 (5)0.8619 (3)0.0404 (17)
C30.3758 (16)0.0808 (5)0.9010 (3)0.0428 (17)
C40.2822 (16)−0.0184 (5)0.8725 (3)0.0425 (17)
C50.3078 (15)−0.0384 (5)0.8042 (3)0.0405 (17)
C60.4583 (15)0.0399 (5)0.7636 (3)0.0387 (17)
C70.5126 (16)0.0209 (5)0.6946 (3)0.0426 (17)
C80.6665 (16)0.0996 (5)0.6597 (3)0.0429 (17)
C90.7713 (17)0.1961 (6)0.6919 (3)0.0462 (17)
H30.344000.094200.946600.0520*
H50.22720−0.102500.785200.0480*
H70.44560−0.043300.673800.0510*
H90.881700.247300.666700.0550*
U11U22U33U12U13U23
Br10.0752 (6)0.0456 (4)0.0506 (5)−0.0125 (3)0.0119 (4)−0.0120 (3)
Br20.0622 (5)0.0498 (5)0.0464 (4)−0.0097 (3)0.0107 (3)0.0057 (3)
Br30.0798 (6)0.0652 (5)0.0385 (4)0.0047 (4)0.0132 (3)−0.0003 (3)
N10.053 (3)0.040 (3)0.039 (3)−0.003 (2)0.003 (2)0.002 (2)
C10.043 (3)0.032 (3)0.044 (3)0.002 (2)0.003 (2)0.002 (2)
C20.044 (3)0.037 (3)0.040 (3)0.002 (2)0.000 (2)−0.004 (2)
C30.042 (3)0.050 (3)0.037 (3)−0.003 (3)0.007 (2)−0.006 (3)
C40.046 (3)0.039 (3)0.043 (3)0.000 (3)0.006 (2)0.003 (2)
C50.045 (3)0.038 (3)0.038 (3)0.000 (2)−0.004 (2)0.000 (2)
C60.039 (3)0.038 (3)0.039 (3)0.006 (2)0.000 (2)0.003 (2)
C70.048 (3)0.041 (3)0.039 (3)0.007 (3)0.005 (2)−0.003 (2)
C80.045 (3)0.047 (3)0.037 (3)0.010 (3)0.004 (2)0.003 (2)
C90.053 (3)0.047 (3)0.039 (3)−0.002 (3)0.006 (3)0.004 (2)
Br1—C21.891 (6)C4—C51.380 (8)
Br2—C41.888 (6)C5—C61.412 (9)
Br3—C81.893 (6)C6—C71.410 (8)
N1—C11.366 (9)C7—C81.359 (9)
N1—C91.303 (8)C8—C91.410 (9)
C1—C21.422 (8)C3—H30.9300
C1—C61.418 (9)C5—H50.9300
C2—C31.359 (9)C7—H70.9300
C3—C41.397 (9)C9—H90.9300
Br1···N13.070 (6)C7···C8ii3.542 (9)
Br1···Br3i3.6969 (12)C7···Br1iv3.738 (6)
Br1···C7i3.738 (6)C8···C7viii3.542 (9)
Br2···C4ii3.696 (6)C9···Br2ix3.553 (7)
Br2···C9iii3.553 (7)C9···C6viii3.587 (9)
Br3···Br1iv3.6969 (12)C5···H9iv2.9800
Br3···Br3v3.8186 (12)H3···Br2vii3.1500
Br1···H7i3.0800H3···Br2vi3.2000
Br2···H9iii3.1000H5···H72.5100
Br2···H3vi3.2000H5···H9iv2.5800
Br2···H9iv3.2400H7···H52.5100
Br2···H3vii3.1500H7···Br1iv3.0800
N1···Br13.070 (6)H9···Br2ix3.1000
C4···Br2viii3.696 (6)H9···Br2i3.2400
C5···C6ii3.572 (8)H9···C5i2.9800
C6···C5viii3.572 (8)H9···H5i2.5800
C6···C9ii3.587 (9)
C1—N1—C9117.9 (6)C5—C6—C7121.5 (6)
N1—C1—C2119.8 (6)C6—C7—C8117.7 (6)
N1—C1—C6122.5 (6)Br3—C8—C7121.1 (5)
C2—C1—C6117.7 (5)Br3—C8—C9118.0 (5)
Br1—C2—C1119.6 (5)C7—C8—C9120.9 (6)
Br1—C2—C3118.8 (5)N1—C9—C8123.0 (6)
C1—C2—C3121.6 (6)C2—C3—H3120.00
C2—C3—C4119.8 (6)C4—C3—H3120.00
Br2—C4—C3118.6 (4)C4—C5—H5120.00
Br2—C4—C5120.0 (5)C6—C5—H5121.00
C3—C4—C5121.4 (6)C6—C7—H7121.00
C4—C5—C6119.0 (6)C8—C7—H7121.00
C1—C6—C5120.3 (5)N1—C9—H9119.00
C1—C6—C7118.1 (5)C8—C9—H9118.00
C9—N1—C1—C2178.4 (6)C2—C3—C4—Br2176.6 (5)
C9—N1—C1—C6−0.9 (9)C2—C3—C4—C5−3.9 (10)
C1—N1—C9—C81.9 (10)Br2—C4—C5—C6−175.1 (5)
N1—C1—C2—Br12.9 (8)C3—C4—C5—C65.4 (9)
N1—C1—C2—C3−176.9 (6)C4—C5—C6—C1−3.0 (9)
C6—C1—C2—Br1−177.8 (4)C4—C5—C6—C7175.5 (6)
C6—C1—C2—C32.5 (9)C1—C6—C7—C80.1 (9)
N1—C1—C6—C5178.5 (6)C5—C6—C7—C8−178.4 (6)
N1—C1—C6—C7−0.1 (9)C6—C7—C8—Br3−179.7 (5)
C2—C1—C6—C5−0.9 (9)C6—C7—C8—C90.8 (9)
C2—C1—C6—C7−179.5 (6)Br3—C8—C9—N1178.6 (5)
Br1—C2—C3—C4−179.9 (5)C7—C8—C9—N1−1.9 (10)
C1—C2—C3—C4−0.2 (9)
Ring 1Ring 2(sym)(Ring 1)···(Ring 2) (Å)
Cg1Cg2i3.802 (4)
  3 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  6,8-Dibromo-quinoline.

Authors:  Ismail Celik; Mehmet Akkurt; Osman Cakmak; Salih Okten; Santiago García-Granda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-31

3.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.